Reports of Guillain-Barré syndrome (GBS) following respiratory syncytial virus (RSV) vaccination in adults ages 60 and up were higher than expected, but the vaccine's benefits still outweigh any small ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New surveillance data from the Vaccine Safety Datalink confirm a small but statistically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results